Delayed access and survival in idiopathic pulmonary fibrosis: A cohort study

American Journal of Respiratory and Critical Care Medicine

Volumn 184, Issue 7, 2011, Pages 842-847

  Lamas, Daniela J ^a   Kawut, Steven M ^b   Bagiella, Emilia ^c   Philip, Nisha ^a   Arcasoy, Selim M ^a   Lederer, David J ^a  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NONE   (United States)

Author keywords

Access to healthcare; Healthcare disparities; Idiopathic pulmonary fibrosis; Interstitial lung disease; Survival

Indexed keywords

ADULT; ARTICLE; CLINICAL EXAMINATION; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPNEA; EVALUATION AND FOLLOW UP; FEMALE; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; HAZARD RATIO; HEALTH CARE DELIVERY; HUMAN; INTENSIVE CARE UNIT; INTERSTITIAL LUNG DISEASE; LUNG FUNCTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK; SURVIVAL TIME; TERTIARY HEALTH CARE;

ADULT; AGED; DELAYED DIAGNOSIS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MALE; MIDDLE AGED; NEW YORK CITY; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; RISK FACTORS; SURVIVAL RATE;

EID: 80053391874     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201104-0668OC     Document Type: Article

References (24)

1. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134:136-151. (Pubitemid 32096342)
2. King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001;164:1171-1181. (Pubitemid 33052246)
3. Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998;351:24-27. (Pubitemid 28020162)
4. Lamas DJ, Kawut SM, Philip N, Arcasoy SM, Lederer DJ. Delayed referral to a tertiary care center is associated with higher mortality in idiopathic pulmonary fibrosis [abstract]. Am J Respir Crit Care Med 2011;183:A5298.
5. American Thoracic Society, European Respiratory Society (ERS). Idiopathic pulmonary fibrosis: diagnosis and treatment: international consensus statement. Am J Respir Crit Care Med 2000;161:646-664.
6. Office of Management and Budget. Recommendations from the Interagency Committee for the Review of the Racial and Ethnic Standards to the Office of Management and Budget Concerning Changes to the Standards for the Classification of Federal Data on Race and Ethnicity. Fed Regist 1997;62:36873-36946.
7. Centers for Disease Control and Prevention. National Health Interview Survey, 2006. Available at http://www.cdc.gov/nchs/nhis/quest-data-related-1997- forward.htm
8. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999;159:179-187. (Pubitemid 29036522)
9. Miller A, Thornton JC, Warshaw R, Anderson H, Teirstein AS, Selikoff IJ. Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state: predicted values, lower limits of normal, and frequencies of abnormality by smoking history. Am Rev Respir Dis 1983;127:270-277. (Pubitemid 13109055)
10. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496-509.
11. Geskus RB. Cause-specific cumulative incidence estimation and the Fine and Gray model under both left truncation and right censoring. Biometrics 2011;67:39-49.
12. Rothman KJ, Greenland S. Immortal person-time. In: Rothman KJ, Greenland S, editors. Modern epidemiology, 2nd ed. Philadelphia: Lippincott-Raven; 1998, p. 87.
13. Cox DR, Oakes D. Analysis of survival data. New York: Chapman & Hall; 1984.
14. Crowley J, Hu M. Covariance analysis of heart transplant survival data. J Am Stat Assoc 1977;72:27-36.
15. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994;81:515-526.
16. Lederer DJ, Caplan-Shaw CE, O'Shea MK, Wilt JS, Basner RC, Bartels MN, Sonett JR, Arcasoy SM, Kawut SM. Racial and ethnic disparities in survival in lung transplant candidates with idiopathic pulmonary fibrosis. Am J Transplant 2006;6:398-403. (Pubitemid 43382178)
17. Lederer DJ, Arcasoy SM, Barr RG, Wilt JS, Bagiella E, D'Ovidio F, Sonett JR, Kawut SM. Racial and ethnic disparities in idiopathic pulmonary fibrosis: a UNOS/OPTN database analysis. Am J Transplant 2006;6:2436-2442. (Pubitemid 44359431)
18. Flaherty KR, King TE Jr, Raghu G, Lynch JP III, Colby TV, Travis WD, Gross BH, Kazerooni EA, Toews GB, Long Q, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med 2004;170:904-910. (Pubitemid 39346487)
19. Flaherty KR, Andrei AC, King TE Jr, Raghu G, Colby TV, Wells A, Bassily N, Brown K, Du Bois R, Flint A, et al. Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am J Respir Crit Care Med 2007;175:1054-1060 (Pubitemid 46741757)
20. Lederer DJ, Enright PL, Kawut SM, Hoffman EA, Hunninghake G, van Beek EJ, Austin JH, Jiang R, Lovasi GS, Barr RG. Cigarette smoking is associated with subclinical parenchymal lung disease: the MESA-Lung Study. Am J Respir Crit Care Med 2009;180:407-414.
21. Rosas IO, Richards TJ, Konishi K, Zhang Y, Gibson K, Lokshin AE, Lindell KO, Cisneros J, Macdonald SD, Pardo A, et al. MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med 2008;5:e93.
22. Flaherty KR, Mumford JA, Murray S, Kazerooni EA, Gross BH, Colby TV, Travis WD, Flint A, Toews GB, Lynch JP 3rd, et al. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003;168:543-548. (Pubitemid 37088596)
23. Collard HR, King TE, Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003;168:538-542. (Pubitemid 37088595)
24. Latsi PI, Du Bois RM, Nicholson AG, Colby TV, Bisirtzoglou D, Nikolakopoulou A, Veeraraghavan S, Hansell DM, Wells AU. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003;168: 531-537. (Pubitemid 37088594)